Abstract
The neural adhesion molecule CD56 is normally expressed on natural killer cells and subsets of T cells and is commonly found in hematolymphoid neoplasms. Expression of CD56 is very rare in B-cell lymphoma and most reported CD56-positive cases were diffuse large B-cell lymphomas. Cases of CD56-positive mantle cell lymphoma (MCL) have not previously been described in the literature. We present a case of CD56-positive MCL. To the best of our knowledge, this is the first case report of MCL expressing CD56.
| Original language | English |
|---|---|
| Pages (from-to) | e111-e114 |
| Journal | Tumori |
| Volume | 98 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- B-cell lymphoma
- CD56
- Immunohistochemistry
- Mantle cell lymphoma
Fingerprint
Dive into the research topics of 'A unique case of blastoid variant of mantle cell lymphoma with an aberrant CD5-/CD10+/Bcl- 6+/CD56+ immunophenotype: A case report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver